Could a quicker switch to stronger meds beat bipolar depression?

NCT ID NCT05973786

Recruiting now Disease control Sponsor: Dr. Inge Winter Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether quickly switching to a more intensive combination of medications helps people with bipolar depression who didn't get better on their first treatment. About 418 adults will either receive standard care or an intensified regimen of antidepressants and mood stabilizers for six weeks. The goal is to see if this approach leads to greater improvement in depression symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a combination of antidepressants (escitalopram, sertraline, venlafaxine, bupropion) and mood stabilizers (lithium, valproate, quetiapine)
What this could lead to: If successful, this could provide a clear treatment strategy for people with bipolar depression who don't respond to their first medication, potentially reducing suffering and improving daily life.
What could go wrong: This is a phase 3 trial, but it's still testing a strategy rather than a new drug. The benefits may be modest, and some participants may experience side effects from the medications. Results may not apply to everyone with bipolar depression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar depression bipolar disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DEPRESSION

Contacts and locations

Locations

Azienda Ospedaliero-Universitaria "Città della Salute e della Scienza di Torino"
RECRUITING

Turin, Italy
Eginition hospital, department of psychiatry
NOT_YET_RECRUITING

Athens, 11528, Greece
Fundació Clínic per a la Recerca Biomèdica
RECRUITING

Barcelona, Spain
King's College London, Psychiatry & Cognitive Neuroscience
NOT_YET_RECRUITING

London, SE5 8AF, United Kingdom
Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz
RECRUITING

Mainz, Germany
LWL-Klinik Dortmund, Bereich Forschung & Wissenschaft
RECRUITING

Dortmund, 44287, Germany
Medical University Innsbruck
RECRUITING

Innsbruck, Austria
Universita degli Studi di Brescia
RECRUITING

Brescia, Italy
University Hospital Frankfurt am Main - Goethe University
RECRUITING

Frankfurt am Main, Germany
University of Cagliari
RECRUITING

Cagliari, Italy
Università degli studi della Campania Luigi Vanvitelli
RECRUITING

Naples, 80138, Italy
Universitätsklinik für Psychiatrie und Psychotherapie Bielefeld
RECRUITING

Bielefeld, Germany
Westfälische Wilhelms-Universität Münster
RECRUITING

Münster, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.